Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Beijing Second Pharmaceutical Receives EU cGMP Certification

This article was originally published in PharmAsia News

Executive Summary

Beijing Second Pharmaceutical, Beijing Pharmaceutical Group's pioneer in going overseas, recently received EU cGMP certification after it initiated an international certification application to be a global pharmaceutical competitor. The company-made anti-hypertensive amlodipine tablets will be sold to Europe and the U.S. within the year, marking a breakthrough for the standard of its pharmaceutical formulation. This also represents a milestone for China's pharmaceutical formulation exports. Industry analysts estimate that the country's nearly 6,000 pharmaceutical firms only account for 3 percent of worldwide drug revenues. Oversupply in the domestic market has led to the profit slump, thus going global is a good strategy for local companies. (Click here for more - Chinese Language)



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts